119 related articles for article (PubMed ID: 37825618)
1. Arsenical Paralysis.
Indep Pract; 1882 May; 3(5):332-333. PubMed ID: 37825618
[No Abstract] [Full Text] [Related]
2. [Syphilis, general paralysis and arsenical therapy].
BOREL J; DARIOSECQ
Concours Med; 1950 Sep; 72(36):2635-7. PubMed ID: 14773164
[No Abstract] [Full Text] [Related]
3. [Paraplegia in a specific (arsenical myelitis)].
COUMEL ; PARAIRE ; HOSOTTE
Presse Med (1893); 1947 Sep; 55(54):617. PubMed ID: 18899412
[No Abstract] [Full Text] [Related]
4. [Landry syndrome by arsenical intoxication of professional origin].
MAZEL P; GUICHARD A
Arch Mal Prof; 1946; 7(1):28-30. PubMed ID: 20988531
[No Abstract] [Full Text] [Related]
5. [Flaccid monoplegia of the left lower extremity appearing suddenly after gluteal intramuscular injection of an arsenical].
DEREUX J; ERNST J
Rev Neurol (Paris); 1951; 84(4):335-7. PubMed ID: 14876220
[No Abstract] [Full Text] [Related]
6. Arsenical keratosis caused by medication: a case report and literature.
Zhou S; Zhou J; Liu S; Wang R; Wang Z
Int J Clin Exp Med; 2015; 8(1):1487-90. PubMed ID: 25785160
[TBL] [Abstract][Full Text] [Related]
7. Clinical Lecture on Arsenical Paralysis.
Da Costa JM
Atlanta Med Surg J; 1881 Apr; 19(1):31-42. PubMed ID: 35826307
[No Abstract] [Full Text] [Related]
8. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.
Fairlamb AH; Smith K; Hunter KJ
Mol Biochem Parasitol; 1992 Jul; 53(1-2):223-31. PubMed ID: 1501642
[TBL] [Abstract][Full Text] [Related]
9. Biological and behavioral factors modify biomarkers of arsenic exposure in a U.S. population.
Calderon RL; Hudgens EE; Carty C; He B; Le XC; Rogers J; Thomas DJ
Environ Res; 2013 Oct; 126():134-44. PubMed ID: 23777639
[TBL] [Abstract][Full Text] [Related]
10. Defective beta1-integrins expression in arsenical keratosis and arsenic-treated cultured human keratinocytes.
Lee CH; Chen JS; Sun YL; Liao WT; Zheng YW; Chai CZ; Chen GS; Yu HS
J Cutan Pathol; 2006 Feb; 33(2):129-38. PubMed ID: 16420308
[TBL] [Abstract][Full Text] [Related]
11. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.
Yu HS; Chang KL; Wang CM; Yu CL
J Dermatol; 1992 Nov; 19(11):710-4. PubMed ID: 1293158
[TBL] [Abstract][Full Text] [Related]
12. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
Suswam EA; Taylor DW; Ross CA; Martin RJ
Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
[TBL] [Abstract][Full Text] [Related]
13. The history of arsenical pesticides and health risks related to the use of Agent Blue.
Bencko V; Yan Li Foong F
Ann Agric Environ Med; 2017 Jun; 24(2):312-316. PubMed ID: 28664715
[TBL] [Abstract][Full Text] [Related]
14. A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury.
Fan XY; Liu YJ; Cai YM; Wang AD; Xia YZ; Hu YJ; Jiang FL; Liu Y
Bioorg Med Chem; 2019 Mar; 27(5):760-768. PubMed ID: 30665675
[TBL] [Abstract][Full Text] [Related]
15. Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China.
Guo X; Fujino Y; Kaneko S; Wu K; Xia Y; Yoshimura T
Mol Cell Biochem; 2001 Jun; 222(1-2):137-40. PubMed ID: 11678595
[TBL] [Abstract][Full Text] [Related]
16. Effects of Long-Term Aging in Arsenical Copper Alloys.
Pereira F; Silva RJ; Monge Soares AM; Araújo MF; Oliveira MJ; Martins RM; Schell N
Microsc Microanal; 2015 Dec; 21(6):1413-1419. PubMed ID: 26494516
[TBL] [Abstract][Full Text] [Related]
17. Treatment of arsenical keratosis and Bowen's disease with acitretin.
Yerebakan O; Ermis O; Yilmaz E; Basaran E
Int J Dermatol; 2002 Feb; 41(2):84-7. PubMed ID: 11982642
[TBL] [Abstract][Full Text] [Related]
18. On Arsenical Disease, or the Disorders Produced by Arsenical Papers and Colours.
Clarke WM
Br Med J; 1873 Jun; 1(651):698-701. PubMed ID: 20747118
[No Abstract] [Full Text] [Related]
19. Arsenical Keratoses: Multiple Basal-Cell Carcinomata and Arsenical "Warts".
Maccormac H
Proc R Soc Med; 1933 Oct; 26(12):1553. PubMed ID: 19989516
[No Abstract] [Full Text] [Related]
20. Cases of (1) Arsenical Jaundice, (2) Arsenical Dermatitis, showing the Results of a Special Treatment.
Chamberlain F
Proc R Soc Med; 1922; 15(Dermatol Sect):26-7. PubMed ID: 19982233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
